Lincoln National Corp’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-3,438
| Closed | -$326K | – | 1140 |
|
|
2024
Q1 | $326K | Buy |
+3,438
| New | +$326K | 0.01% | 925 |
|
|
2023
Q3 | – | Sell |
-2,572
| Closed | -$214K | – | 1068 |
|
|
2023
Q2 | $214K | Sell |
2,572
-95
| -4% | -$7.91K | ﹤0.01% | 940 |
|
|
2023
Q1 | $203K | Sell |
2,667
-524
| -16% | -$39.9K | ﹤0.01% | 928 |
|
|
2022
Q4 | $265K | Sell |
3,191
-3,427
| -52% | -$284K | 0.01% | 770 |
|
|
2022
Q3 | $525K | Buy |
6,618
+1,416
| +27% | +$112K | 0.01% | 482 |
|
|
2022
Q2 | $386K | Sell |
5,202
-136
| -3% | -$10.1K | 0.01% | 558 |
|
|
2022
Q1 | $480K | Buy |
5,338
+1,946
| +57% | +$175K | 0.01% | 540 |
|
|
2021
Q4 | $380K | Buy |
3,392
+261
| +8% | +$29.2K | 0.01% | 628 |
|
|
2021
Q3 | $394K | Buy |
3,131
+114
| +4% | +$14.3K | 0.01% | 583 |
|
|
2021
Q2 | $409K | Hold |
3,017
| – | – | 0.01% | 552 |
|
|
2021
Q1 | $409K | Buy |
3,017
+109
| +4% | +$14.8K | 0.01% | 513 |
|
|
2020
Q4 | $409K | Buy |
2,908
+349
| +14% | +$49.1K | 0.01% | 479 |
|
|
2020
Q3 | $285K | Buy |
2,559
+338
| +15% | +$37.6K | 0.01% | 524 |
|
|
2020
Q2 | $249K | Buy |
+2,221
| New | +$249K | 0.01% | 539 |
|
|
2020
Q1 | – | Sell |
-4,921
| Closed | -$468K | – | 677 |
|
|
2019
Q4 | $468K | Buy |
+4,921
| New | +$468K | 0.02% | 410 |
|
|
2018
Q1 | – | Sell |
-2,442
| Closed | -$207K | – | 626 |
|
|
2017
Q4 | $207K | Buy |
+2,442
| New | +$207K | 0.01% | 589 |
|
|
2017
Q3 | – | Sell |
-5,321
| Closed | -$411K | – | 413 |
|
|
2017
Q2 | $411K | Buy |
+5,321
| New | +$411K | 0.02% | 218 |
|